Janux Therapeutics, Inc. · NASDAQ:JANX
State Street Corp reported a 6.40% stake in Janux Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 9, 2026
State Street Corp reported a 6.40% stake in Janux Therapeutics, Inc., 3,853,951 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G).
- Stake
- 6.40%
- Shares
- 3,853,951
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 6.40% | 3,853,951 |
Source
Related
- Janux Therapeutics, Inc.
- State Street Corp
- Janux Therapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · May 12, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026